Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,920.00    -14.00 (-0.28%)
Bid:
4,906.00
Ask:
4,908.00
Spread: 2.00 (0.041%)
Market Cap: £17.93b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

4 Jan 2022 09:54

RNS Number : 3425X
Coca-Cola HBC AG
04 January 2022
 

FOR IMMEDIATE RELEASE

04 January 2022

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that the deferred bonus award over shares of CHF 6.70 in the Company (the "Deferred Shares") granted under the Company's Management Incentive Plan to Zoran Bogdanovic, Chief Executive Officer, relating to a performance related annual bonus for 2018 vested on 31 December 2021. Following vesting, the PDMR sold sufficient Deferred Shares to cover his tax and other liabilities and the balance of the Deferred Shares was retained.

 PDMR

Number of shares granted under the Deferred Shares vesting

Number of shares sold to cover taxes and other liabilities

Number of shares retained

Zoran Bogdanovic, Chief Executive Officer

7,717

450

7,267

 

The Notification of Dealing Form can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

ZORAN BOGDANOVIC

 

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF EXECUTIVE OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

VESTING OF DEFERRED SHARES GRANTED IN MARCH 2019 UNDER THE COMPANY'S MANAGEMENT INCENTIVE PLAN

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

7,717

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

7,717

196,551.99 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE DEFERRED SHARES

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

450

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

450

11,461.50 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

 

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKQBPCBKKBDK
Date   Source Headline
19th Mar 20182:54 pmRNSDirector/PDMR Shareholding
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares
1st Jun 20177:54 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.